Asston Pharmaceuticals Ltd — Important, 02-07-2026: Company Update

Asston Pharmaceuticals' board has approved a preferential issue of up to 24,10,431 equity shares. These shares, priced at ₹115 each, will raise approximately ₹27.72 crore from non-promoter investors for cash, aiming to bolster the company's capital. The board also approved convening an Extraordinary General Meeting on July 31st, to seek shareholder approval for this preferential allotment. This capital infusion, if approved, is significant for the company's financial operations and future growth plans, providing funds for its business.